Chronic obstructive pulmonary disease (COPD) is a term used to describe 2 related lung diseases: chronic bronchitis and emphysema. Chronic bronchitis is inflammation and eventual scarring of the bronchi (airway tubes). Emphysema is enlargement and destruction of the alveoli (air sacs) within the lungs. Many persons with COPD have both of these conditions.
Persons with COPD have difficulty breathing because they develop smaller air passageways and have partially destroyed alveoli. The air passageways also become clogged with mucus, a slimy substance. Smoking cigarettes is the most important risk factor and cause of COPD. About 80% to 90% of COPD cases are caused by smoking, and a smoker is 10 times more likely than a nonsmoker to die of COPD. The November 5, 2003, issue of JAMA includes an article about treatments for COPD.
Grahic Jump Location
Chronic cough
Increased sputum (mucus coughed from the airways)
Shortness of breath
Limitation of physical activity
Stopping smoking—extremely important to prevent worsening of the disease
Bronchodilators—medications, often taken by an inhaler, that help open air passageways in the lungs
Corticosteroids—medications taken by inhaler to counteract inflammation in the air passages and lungs
Oxygen—can help patients with COPD who have a hard time getting enough oxygen; often stored in a portable tank
Antibiotics—can be helpful for fighting bacterial infections that make symptoms of COPD worse
National Heart, Lung, and Blood Institute (301) 592-8573http://www.nhlbi.nih.gov
American Lung Association 800/LUNG-USA ( 800/586-4872)http://www.lungusa.org
To find this and other JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on quitting smoking was published in the July 24/31, 2002, issue; and one on lung disease was published in the April 12, 2000, issue.
Sources: National Heart, Lung, and Blood Institute; American Lung Association; American Heart Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.
TOPIC: LUNG DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Consider an RCT of corticosteroids in patients with an acute exacerbation of chronic obstructive...
Users' Guides to the Medical Literature For example, in a study examining HRQL in patients with chronic airflow limitation who were...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.